| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |